sglt2 inhibitors vs glp 1 agonists vs. GLP-1 to Treat the Heart, the Kidneys and the Brain Renal outcomes of SGLT2 inhibitors
Description
It is not intended as medical advice, diagnosis, or treatment
Try a bathroom routine after breakfast
Lancet Diabetes Endocrinol
At the end of the study, cells were fixed with 4% paraformaldehyde for 10 minutes, washed in PBS, and blocked in PBS plus 2% BSA for 45 minutes
BMJ Open 2024;14:e083550
The hypothesis was that tirzepatide would reduce LV mass and epicardial adipose tissue (EAT) in these patients
